MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 1999-06-08 for ABBOTT HCV EIA 2.0 4A14-24 manufactured by Abbott Laboratories.
[19166019]
On 12/29/1998, a pt tested positive with the hepatitis c virus 2. 0 eia assay. The sample was repeated in duplicate and both results were positive. The pt was referred to the clinic for liver biopsy and repeat hepatitis c virus testing. Both results were negative. On 4/9/1999, the pt tested negative with the hepatitis c virus 2. 0 eia assay. The sample from 4/9/1999 was then sent to the clinic, which also reported negative results.
Patient Sequence No: 1, Text Type: D, B5
| Report Number | 1415939-1999-00006 |
| MDR Report Key | 226924 |
| Report Source | 05,06 |
| Date Received | 1999-06-08 |
| Date of Report | 1999-06-07 |
| Date of Event | 1998-12-29 |
| Date Mfgr Received | 1999-05-10 |
| Device Manufacturer Date | 1998-11-01 |
| Date Added to Maude | 1999-06-15 |
| Event Key | 0 |
| Report Source Code | Manufacturer report |
| Manufacturer Link | Y |
| Number of Patients in Event | 0 |
| Adverse Event Flag | 3 |
| Product Problem Flag | 3 |
| Reprocessed and Reused Flag | 0 |
| Reporter Occupation | MEDICAL TECHNOLOGIST |
| Health Professional | 3 |
| Initial Report to FDA | 3 |
| Report to FDA | 3 |
| Event Location | 0 |
| Manufacturer Contact | PAUL LANDESMAN |
| Manufacturer Street | 200 ABBOTT PARK RD. |
| Manufacturer City | ABBOTT PARK IL 600643500 |
| Manufacturer Country | US |
| Manufacturer Postal | 600643500 |
| Manufacturer Phone | * |
| Manufacturer G1 | * |
| Manufacturer Street | * |
| Manufacturer City | * |
| Manufacturer Country | * |
| Single Use | 3 |
| Previous Use Code | 3 |
| Event Type | 3 |
| Type of Report | 3 |
| Brand Name | ABBOTT HCV EIA 2.0 |
| Generic Name | EIA FOR DETECTION OF HCV ANTIBODY |
| Product Code | LQI |
| Date Received | 1999-06-08 |
| Model Number | NA |
| Catalog Number | 4A14-24 |
| Lot Number | 47020M100 |
| ID Number | NA |
| Device Expiration Date | 1999-05-26 |
| Operator | HEALTH PROFESSIONAL |
| Device Availability | N |
| Device Eval'ed by Mfgr | N |
| Implant Flag | N |
| Date Removed | * |
| Device Sequence No | 1 |
| Device Event Key | 220047 |
| Manufacturer | ABBOTT LABORATORIES |
| Manufacturer Address | 100 ABBOTT PARK RD ABBOTT PARK IL 600643500 US |
| Baseline Brand Name | ABBOTT HCV EIA 2.0 |
| Baseline Generic Name | EIA FOR DETECTION OF HCV ANTIBODY |
| Baseline Model No | NA |
| Baseline Catalog No | 4A14-24 |
| Baseline ID | NA |
| Baseline Device Family | ABBOTT HCV EIA 2.0 |
| Baseline Shelf Life Contained | N |
| Baseline Shelf Life [Months] | 12 |
| Baseline PMA Flag | N |
| Baseline 510K PMN | N |
| Baseline Preamendment | N |
| Baseline Transitional | N |
| 510k Exempt | N |
| Patient Number | Treatment | Outcome | Date |
|---|---|---|---|
| 1 | 0 | 1. Other | 1999-06-08 |